{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:14:31Z","timestamp":1783671271041,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Undergraduate Innovation Training Program of Zhengzhou University","award":["2025cxcy575"],"award-info":[{"award-number":["2025cxcy575"]}]},{"DOI":"10.13039\/501100004761","name":"The Natural Science Foundation of Henan Province","doi-asserted-by":"crossref","award":["242300420066"],"award-info":[{"award-number":["242300420066"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12015-026-11174-w","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:42:24Z","timestamp":1781854944000},"page":"2938-2957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["2-Methoxyestradiol Suppresses Stemness and Epithelial-Mesenchymal Transition in Drug-Resistant Esophageal Squamous Cell Carcinoma by Targeting the Snail Signaling Pathway in Cancer Stem Cells"],"prefix":"10.1007","volume":"22","author":[{"given":"Jie","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"4","key":"11174_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1620\/tjem.240.295","volume":"240","author":"R Wang","year":"2016","unstructured":"Wang, R., Sumarpo, A., Saiki, Y., et al. (2016). ABCB1 Is Upregulated in Acquisition of Taxane Resistance: Lessons from Esophageal Squamous Cell Carcinoma Cell Lines. Tohoku Journal Of Experimental Medicine, 240(4), 295\u2013301. https:\/\/doi.org\/10.1620\/tjem.240.295","journal-title":"Tohoku Journal Of Experimental Medicine"},{"issue":"2","key":"11174_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00018-022-04131-6","volume":"79","author":"M Lohan-Code\u00e7o","year":"2022","unstructured":"Lohan-Code\u00e7o, M., Barambo-Wagner, M. L., Nasciutti, L. E., et al. (2022). Molecular mechanisms associated with chemoresistance in esophageal cancer. Cellular And Molecular Life Sciences, 79(2), 116. https:\/\/doi.org\/10.1007\/s00018-022-04131-6","journal-title":"Cellular And Molecular Life Sciences"},{"issue":"7","key":"11174_CR3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41401-021-00787-1","volume":"43","author":"Y Li","year":"2022","unstructured":"Li, Y., Ren, B. X., Li, H. M., et al. (2022). Omeprazole suppresses aggressive cancer growth and metastasis in mice through promoting Snail degradation. Acta Pharmacologica Sinica, 43(7), 1816\u20131828. https:\/\/doi.org\/10.1038\/s41401-021-00787-1","journal-title":"Acta Pharmacologica Sinica"},{"key":"11174_CR4","doi-asserted-by":"publisher","unstructured":"Liu, X., He, M., Li, L., et al. (2021). EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer. Frontiers In Oncology, 3;11:672222. https:\/\/doi.org\/10.3389\/fonc.2021.672222","DOI":"10.3389\/fonc.2021.672222"},{"issue":"7","key":"11174_CR5","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s12015-023-10593-3","volume":"19","author":"Q Gao","year":"2023","unstructured":"Gao, Q., Zhan, Y., Sun, L., & Zhu, W. (2023). Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance. Stem Cell Rev Rep, 19(7), 2141\u20132154. https:\/\/doi.org\/10.1007\/s12015-023-10593-3","journal-title":"Stem Cell Rev Rep"},{"issue":"6","key":"11174_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s12015-023-10529-x","volume":"19","author":"T Nairuz","year":"2023","unstructured":"Nairuz, T., Mahmud, Z., Manik, R. K., & Kabir, Y. (2023). Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance. Stem Cell Rev Rep, 19(6), 1577\u20131595. https:\/\/doi.org\/10.1007\/s12015-023-10529-x","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"11174_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I., & Blanpain, C. (2019). EMT Transition States during Tumor Progression and Metastasis. Trends In Cell Biology, 29(3), 212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001","journal-title":"Trends In Cell Biology"},{"issue":"1","key":"11174_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41392-023-01710-2","volume":"8","author":"L Chen","year":"2023","unstructured":"Chen, L., Zhu, S., Liu, T., et al. (2023). Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression. Signal Transduct Target Ther, 8(1), 453. https:\/\/doi.org\/10.1038\/s41392-023-01710-2. Published 2023 Dec 15.","journal-title":"Signal Transduct Target Ther"},{"key":"11174_CR9","doi-asserted-by":"publisher","first-page":"216723","DOI":"10.1016\/j.canlet.2024.216723","volume":"587","author":"D Guo","year":"2024","unstructured":"Guo, D., Sheng, K., Zhang, Q., et al. (2024). Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma. Cancer Letters, 587, 216723. https:\/\/doi.org\/10.1016\/j.canlet.2024.216723","journal-title":"Cancer Letters"},{"issue":"21","key":"11174_CR10","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1158\/0008-5472.CAN-16-0366","volume":"76","author":"L Alba-Castellon","year":"2016","unstructured":"Alba-Castellon, L., Olivera-Salguero, R., Mestre-Farrera, A., et al. (2016). Snail1-Dependent Activation of Cancer-Associated Fibroblast Controls Epithelial Tumor Cell Invasion and Metastasis. Cancer Research, 76(21), 6205\u20136217. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0366","journal-title":"Cancer Research"},{"key":"11174_CR11","doi-asserted-by":"publisher","unstructured":"Li, H-M., Bi, Y-R., Li, Y., et al. (2020). A potent CBP\/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer. Science Advances, 6(17):eaaw8500. https:\/\/doi.org\/10.1126\/sciadv.aay4179","DOI":"10.1126\/sciadv.aay4179"},{"key":"11174_CR12","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.2147\/OTT.S81941","volume":"8","author":"SS Wang","year":"2015","unstructured":"Wang, S. S., Jiang, J., Liang, X. H., et al. (2015). Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther, 8, 2973\u20132980. https:\/\/doi.org\/10.2147\/OTT.S81941","journal-title":"Onco Targets Ther"},{"key":"11174_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13046-014-0066-5","volume":"33","author":"S Kaufhold","year":"2014","unstructured":"Kaufhold, S., & Bonavida, B. (2014). Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. Journal Of Experimental & Clinical Cancer Research : Cr, 33, 66. https:\/\/doi.org\/10.1186\/s13046-014-0066-5","journal-title":"Journal Of Experimental & Clinical Cancer Research : Cr"},{"issue":"1","key":"11174_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-020-01224-9","volume":"19","author":"Z Pan","year":"2020","unstructured":"Pan, Z., Cai, J., Lin, J., et al. (2020). A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer. Molecular Cancer, 19(1), 101. https:\/\/doi.org\/10.1186\/s12943-020-01224-9","journal-title":"Molecular Cancer"},{"issue":"1","key":"11174_CR15","doi-asserted-by":"publisher","first-page":"e85512","DOI":"10.1371\/journal.pone.0085512","volume":"9","author":"W Zhou","year":"2014","unstructured":"Zhou, W., Lv, R., Qi, W., et al. (2014). Snail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer. PLoS One, 9(1), e85512. https:\/\/doi.org\/10.1371\/journal.pone.0085512","journal-title":"PLoS One"},{"issue":"1","key":"11174_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1053\/j.gastro.2011.03.044","volume":"141","author":"WL Hwang","year":"2011","unstructured":"Hwang, W. L., Yang, M. H., Tsai, M. L., et al. (2011). SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology, 141(1), 279\u2013291. https:\/\/doi.org\/10.1053\/j.gastro.2011.03.044","journal-title":"Gastroenterology"},{"issue":"9","key":"11174_CR17","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.xphs.2017.03.011","volume":"106","author":"T Tomono","year":"2017","unstructured":"Tomono, T., Yano, K., & Ogihara, T. (2017). Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells. Journal Of Pharmaceutical Sciences, 106(9), 2642\u20132649. https:\/\/doi.org\/10.1016\/j.xphs.2017.03.011","journal-title":"Journal Of Pharmaceutical Sciences"},{"key":"11174_CR18","doi-asserted-by":"publisher","first-page":"105939","DOI":"10.1016\/j.phrs.2021.105939","volume":"174","author":"J Zhao","year":"2021","unstructured":"Zhao, J., Li, L., Wang, Z., et al. (2021). Luteolin attenuates cancer cell stemness in PTX-resistant oesophageal cancer cells through mediating SOX2 protein stability. Pharmacological Research, 174, 105939. https:\/\/doi.org\/10.1016\/j.phrs.2021.105939","journal-title":"Pharmacological Research"},{"key":"11174_CR19","doi-asserted-by":"publisher","first-page":"672222","DOI":"10.3389\/fonc.2021.672222","volume":"11","author":"X Liu","year":"2021","unstructured":"Liu, X., He, M., Li, L., et al. (2021). EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer. Frontiers In Oncology, 11, 672222. https:\/\/doi.org\/10.3389\/fonc.2021.672222. Published 2021 Jun 3.","journal-title":"Frontiers In Oncology"},{"key":"11174_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejmech.2019.05.027","volume":"176","author":"C Wang","year":"2019","unstructured":"Wang, C., Li, L., Fu, D., et al. (2019). Discovery of chalcone-modified estradiol analogs as antitumour agents that Inhibit tumour angiogenesis and epithelial to mesenchymal transition. European Journal Of Medicinal Chemistry, 176, 135\u2013148. https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.027","journal-title":"European Journal Of Medicinal Chemistry"},{"issue":"4","key":"11174_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4155\/fmc-2019-0247","volume":"12","author":"M Ba","year":"2020","unstructured":"Ba, M., & Duan, Y. (2020). Advance of 2-methoxyestradiol as a promising anticancer agent for cancer therapy. Future Med Chem, 12(4), 273\u2013275. https:\/\/doi.org\/10.4155\/fmc-2019-0247","journal-title":"Future Med Chem"},{"issue":"1","key":"11174_CR22","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1186\/s12885-024-12871-w","volume":"24","author":"B Deswal","year":"2024","unstructured":"Deswal, B., Bagchi, U., Santra, M. K., Garg, M., & Kapoor, S. (2024). Inhibition of STAT3 by 2-Methoxyestradiol suppresses M2 polarization and protumoral functions of macrophages in breast cancer. Bmc Cancer, 24(1), 1129. https:\/\/doi.org\/10.1186\/s12885-024-12871-w. Published 2024 Sep 10.","journal-title":"Bmc Cancer"},{"issue":"24","key":"11174_CR23","doi-asserted-by":"publisher","first-page":"10785","DOI":"10.26355\/eurrev_201912_19781","volume":"23","author":"YR Lu","year":"2019","unstructured":"Lu, Y. R., Song, J., Zhabihula, B. X., & Zhang, J. R. (2019). 2-Methoxyestradiol promotes radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1\u03b1 expression. European Review For Medical And Pharmacological Sciences, 23(24), 10785\u201310795. https:\/\/doi.org\/10.26355\/eurrev_201912_19781","journal-title":"European Review For Medical And Pharmacological Sciences"},{"issue":"6","key":"11174_CR24","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10637-010-9455-x","volume":"29","author":"MR Harrison","year":"2011","unstructured":"Harrison, M. R., Hahn, N. M., Pili, R., et al. (2011). A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal\u00ae dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Invest New Drugs, 29(6), 1465\u20131474. https:\/\/doi.org\/10.1007\/s10637-010-9455-x","journal-title":"Invest New Drugs"},{"issue":"6","key":"11174_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00001622-200311000-00004","volume":"15","author":"SL Mooberry","year":"2003","unstructured":"Mooberry, S. L. (2003). New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent. Current Opinion In Oncology, 15(6), 425\u2013430. https:\/\/doi.org\/10.1097\/00001622-200311000-00004","journal-title":"Current Opinion In Oncology"},{"issue":"24","key":"11174_CR26","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1158\/1078-0432.CCR-04-1393","volume":"10","author":"JL Ricker","year":"2004","unstructured":"Ricker, J. L., Chen, Z., Yang, X. P., Pribluda, V. S., Swartz, G. M., & Van Waes, C. (2004). 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clinical Cancer Research, 10(24), 8665\u20138673. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-1393","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"11174_CR27","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1158\/1535-7163.MCT-08-0442","volume":"7","author":"TY Liaw","year":"2008","unstructured":"Liaw, T. Y., Salam, N. K., McKay, M. J., Cunningham, A. M., Hibbs, D. E., & Kavallaris, M. (2008). Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions. Molecular Cancer Therapeutics, 7(10), 3150\u20133159. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0442","journal-title":"Molecular Cancer Therapeutics"},{"issue":"1","key":"11174_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41392-023-01544-4","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang, N., Ma, T., & Yu, B. (2023). Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Ther, 8(1), 327. https:\/\/doi.org\/10.1038\/s41392-023-01544-4","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"11174_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S., & Weinberg, R. A. (2011). Tumor metastasis: molecular insights and evolving paradigms. Cell, 147(2), 275\u2013292. https:\/\/doi.org\/10.1016\/j.cell.2011.09.024","journal-title":"Cell"},{"issue":"1","key":"11174_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-016-0336-7","volume":"9","author":"A Jayachandran","year":"2016","unstructured":"Jayachandran, A., Dhungel, B., & Steel, J. C. (2016). Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma. Journal Of Hematology & Oncology, 9(1), 112. https:\/\/doi.org\/10.1186\/s13045-016-0336-7","journal-title":"Journal Of Hematology & Oncology"},{"key":"11174_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/1471-2407-12-394","volume":"12","author":"AM Haslehurst","year":"2012","unstructured":"Haslehurst, A. M., Koti, M., Dharsee, M., et al. (2012). EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. Bmc Cancer, 12, 394. https:\/\/doi.org\/10.1186\/1471-2407-12-394","journal-title":"Bmc Cancer"},{"issue":"5","key":"11174_CR32","doi-asserted-by":"publisher","first-page":"eaaw4908","DOI":"10.1126\/sciadv.aaw4908","volume":"5","author":"M Sonego","year":"2019","unstructured":"Sonego, M., Pellarin, I., Costa, A., et al. (2019). USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Science Advances, 5(5), eaaw4908. https:\/\/doi.org\/10.1126\/sciadv.aaw4908","journal-title":"Science Advances"},{"key":"11174_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.semcancer.2014.02.003","volume":"27","author":"I Muqbil","year":"2014","unstructured":"Muqbil, I., Wu, J., Aboukameel, A., et al. (2014). Snail nuclear transport: The gateways regulating epithelial-to-mesenchymal transition? Semin Cancer Biol, 27, 39\u201345. https:\/\/doi.org\/10.1016\/j.semcancer.2014.02.003","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"11174_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4161\/cbt.5.1.2349","volume":"5","author":"WL Dahut","year":"2006","unstructured":"Dahut, W. L., Lakhani, N. J., Gulley, J. L., et al. (2006). Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biology & Therapy, 5(1), 22\u201327. https:\/\/doi.org\/10.4161\/cbt.5.1.2349","journal-title":"Cancer Biology & Therapy"},{"issue":"16","key":"11174_CR35","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1158\/1078-0432.CCR-05-0724","volume":"11","author":"C Sidor","year":"2005","unstructured":"Sidor, C., D\u2019Amato, R., & Miller, K. D. (2005). The potential and suitability of 2-methoxyestradiol in cancer therapy. Clinical Cancer Research, 11(16), 6094\u20136096. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0724","journal-title":"Clinical Cancer Research"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11174-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:27:47Z","timestamp":1783668467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11174-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11174"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11174-w","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}